Colorectal cancer (CRC) cells releasing CCL20 attracted Tregs, fostering chemoresistance through FOXO1/CEBPB/NF-κB signaling, which could be a promising strategy for treating CRC [61]. The gene discussed is FOXO1; the disease is colorectal cancer.